Name
Edison histotripsy
Alternate Names
None
Abbreviations
None
Category
Other therapy
Subcategory
None
NSC Number
None
Primary Site
Liver
Histology
None
Remarks
IMPORTANT NOTE: Edison histotripsy is a non-surgical treatment for liver tumors and is coded A170 in the surgical data field. This was added to SEER*RX for coding instructions.
November 17, 2023 FDA has granted approval for the Histo¬Sonics’ Edison histotripsy device to treat liver tumors.
Histotripsy, a novel therapeutic tech¬nique, targets and destroys diseased tissues, including cancerous tumors, without the need for invasive surgery.
Instead of traditional surgical methods or radiation, histotripsy employs the power of high-intensity focused ultra¬sound to fragment and liquefy target¬ed tissues. This noninvasive approach enables more precise treatment while minimizing the risks associated with invasive surgery, making it a gamechanger in the medical field.
November 17, 2023 FDA has granted approval for the Histo¬Sonics’ Edison histotripsy device to treat liver tumors.
Histotripsy, a novel therapeutic tech¬nique, targets and destroys diseased tissues, including cancerous tumors, without the need for invasive surgery.
Instead of traditional surgical methods or radiation, histotripsy employs the power of high-intensity focused ultra¬sound to fragment and liquefy target¬ed tissues. This noninvasive approach enables more precise treatment while minimizing the risks associated with invasive surgery, making it a gamechanger in the medical field.
Coding
Please see remarks for additional information